For several years, I have been conducting research on the power relationships at play in health and environmental policies, on the production of scientific knowledge and on the circulation of molecules (industrial chemicals, drugs, pesticides). My work focuses in particular on the role of corporations in regulating the commodities they produce.
In the AMAGRI project, I am investigating both public policies adopted to regulate the prescription of antibiotics in livestock production and the production of an international expertise on antimicrobial resistance. I am particularly interested in the veterinary drug package adopted by the European Union at the beginning of 2019 and the forms of knowledge and expertise used to categorise certain drugs as "critical antibiotics" in various bodies (in particular the European Medicines Agency and the World Health Organisation).
In 2017-2019, I was involved in the MEDICI project, which focused on the trajectory and uses of the notion of "conflict of interest" in the field of medicines. This project's objective was to follow the methods of problematization and management of conflict of interest, the tools used to limit their effects, and the disputes that they support. As part of my thesis and a project funded by IFRIS, I worked on the construction of "regulatory knowledge" mobilized in the expertise on chemicals, through the cases of the US Toxic Substances Control Act of 1976 and the European REACH Regulation of 2006. The latter is at the heart of the book I published with Éditions La Découverte.